THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Therapeutic Solutions International, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q3 2024.
  • Therapeutic Solutions International, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.01M, a 67.4% decline year-over-year.
  • Therapeutic Solutions International, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$2.41M, a 14.5% increase year-over-year.
  • Therapeutic Solutions International, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$2.17M, a 43.1% increase from 2022.
  • Therapeutic Solutions International, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.81M, a 28.8% decline from 2021.
  • Therapeutic Solutions International, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$2.96M, a 34.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.41M -$1.01M -$405K -67.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-20
Q2 2024 -$2M -$390K +$172K +30.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$2.18M -$585K -$7.26K -1.26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-30
Q4 2023 -$2.17M -$427K +$648K +60.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-17
Q3 2023 -$2.82M -$602K +$344K +36.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-20
Q2 2023 -$3.16M -$562K +$628K +52.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$3.79M -$578K +$23K +3.83% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-30
Q4 2022 -$3.81M -$1.08M +$247K +18.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-17
Q3 2022 -$4.06M -$946K -$132K -16.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.93M -$1.19M -$554K -86.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$3.38M -$601K -$414K -221% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-16
Q4 2021 -$2.96M -$1.32M -$479K -56.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$2.48M -$815K -$315K -63% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-17
Q2 2021 -$2.17M -$637K +$252K +28.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-19
Q1 2021 -$2.42M -$187K -$219K -682% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$2.2M -$843K +$212K +20.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$2.41M -$500K -$53.8K -12% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$2.36M -$889K -$661K -290% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$1.7M $32.1K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-21
Q4 2019 -$1.7M -$1.06M -$238K -29.1% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-12
Q3 2019 -$1.46M -$446K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$1.46M -$228K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-24
Q1 2019 -$1.46M $32.1K +$407K Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-05-21
Q4 2018 -$1.87M -$818K -$789K -2749% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-21
Q3 2018 -$1.08M -$446K -$278K -166% Jul 1, 2018 Sep 30, 2018 10-Q 2020-11-17
Q2 2018 -$800K -$228K +$385K +62.8% Apr 1, 2018 Jun 30, 2018 10-Q/A 2020-08-24
Q1 2018 -$1.18M -$375K -$189K -102% Jan 1, 2018 Mar 31, 2018 10-Q/A 2020-07-09
Q4 2017 -$995K -$28.7K +$343K +92.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-15
Q3 2017 -$1.34M -$168K +$15K +8.19% Jul 1, 2017 Sep 30, 2017 10-Q 2019-11-20
Q2 2017 -$1.35M -$613K -$333K -119% Apr 1, 2017 Jun 30, 2017 10-Q 2019-08-16
Q1 2017 -$1.02M -$186K +$42.8K +18.7% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-05-22
Q4 2016 -$1.06M -$371K -$163K -78% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$900K -$183K -$2.95K -1.64% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-16
Q2 2016 -$897K -$280K -$158K -130% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$739K -$229K -$153K -200% Jan 1, 2016 Mar 31, 2016 10-Q 2017-07-05
Q4 2015 -$586K -$209K +$9.96K +4.56% Oct 1, 2015 Dec 31, 2015 10-K 2016-10-31
Q3 2015 -$596K -$180K -$215K -615% Jul 1, 2015 Sep 30, 2015 10-Q 2017-04-17
Q2 2015 -$382K -$122K -$60.8K -99.8% Apr 1, 2015 Jun 30, 2015 10-Q 2017-04-13
Q1 2015 -$321K -$76.2K -$32.1K -72.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-07-06
Q4 2014 -$289K -$219K -$167K -321% Oct 1, 2014 Dec 31, 2014 10-K 2016-10-31
Q3 2014 -$122K $34.9K +$144K Jul 1, 2014 Sep 30, 2014 10-Q 2016-08-23
Q2 2014 -$266K -$61K +$163K +72.8% Apr 1, 2014 Jun 30, 2014 10-Q 2016-05-09
Q1 2014 -$429K -$44.1K +$122K +73.5% Jan 1, 2014 Mar 31, 2014 10-Q 2016-07-06
Q4 2013 -$552K -$51.9K +$277K +84.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-06-16
Q3 2013 -$829K -$109K -$371K -142% Jul 1, 2013 Sep 30, 2013 10-Q 2016-05-13
Q2 2013 -$458K -$224K +$136K +37.8% Apr 1, 2013 Jun 30, 2013 10-Q 2016-05-09
Q1 2013 -$594K -$166K +$211K +56% Jan 1, 2013 Mar 31, 2013 10-Q 2016-04-28
Q4 2012 -$806K -$329K +$205K +38.4% Oct 1, 2012 Dec 31, 2012 10-K 2016-04-22
Q3 2012 -$1.01M $262K +$640K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$1.65M -$361K -$312K -633% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$1.34M -$378K -$368K -3699% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$971K -$533K -$526K -6867% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$445K -$378K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-29
Q2 2011 -$49.2K Apr 1, 2011 Jun 30, 2011 10-Q 2012-11-21
Q1 2011 -$9.94K Jan 1, 2011 Mar 31, 2011 10-Q 2012-11-19
Q4 2010 -$7.66K Sep 21, 2010 Dec 31, 2010 10-K 2012-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.